{
    "clinical_study": {
        "@rank": "90663", 
        "arm_group": [
            {
                "arm_group_label": "Atenolol", 
                "arm_group_type": "Experimental", 
                "description": "In each group, premedication with either b-blocker (Atenolol) or ACE inhibitor (enalapril) or nothing (control group) in the preparation room."
            }, 
            {
                "arm_group_label": "Enalapril", 
                "arm_group_type": "Active Comparator", 
                "description": "In each group, premedication with either b-blocker (Atenolol) or ACE inhibitor (enalapril) or nothing (control group) in the preparation room."
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "none of antihypertensive agents"
            }
        ], 
        "brief_summary": {
            "textblock": "For those who receive hypotensive anesthesia in orthognathic surgeries, the investigators\n      premedicate with anti-hypertensive agent so that it decreases the occurence of tachycardia\n      and the rebound hypertension due to hypotensive anesthesia, enabling us to compare\n      hemodynamic stability and reduction of anesthetic agents during the operation."
        }, 
        "brief_title": "The Effect of Antihypertensive Agents Concerning With Hemodynamics and Reduction of Anaesthetics in Orthognathic Surgery", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Orthognathic Surgery", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. ASA class I-II\n\n          2. obtaining written informed consent from the parents\n\n          3. aged 18-29 years who were undergoing orthognathic surgery.\n\n        Exclusion Criteria:\n\n          1. Hypertension patients with anti-hypertensive agents\n\n          2. chronic renal failure or End stage renal disease patients.\n\n          3. renal artery stenosis history.\n\n          4. Patients who are with medication due to systemic disease.\n\n          5. symptomatic asthma\n\n          6. Drug hyperactivity\n\n          7. neurological or psychiatric illnesses\n\n          8. mental retardation\n\n          9. patients who can`t read the consent form due to illiterate or foreigner"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "29 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01839253", 
            "org_study_id": "4-2012-0422"
        }, 
        "intervention": [
            {
                "arm_group_label": "Atenolol", 
                "intervention_name": "b-blocker(Atenolol)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Enalapril", 
                "intervention_name": "ACE inhibitor(Enapril)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "control", 
                "intervention_name": "control", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Angiotensin-Converting Enzyme Inhibitors", 
                "Antihypertensive Agents", 
                "Atenolol"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "antihypertensive agents", 
            "hemodynamic", 
            "anesthetics reduction", 
            "orthognathic surgery"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Total minutes when the MAP is lower than 55mmHg and higher than 65mmHg (min) , The time below 55 mmHg(min) , The total time above 65 mmHg (min) Total remifentanil amount, total NTG amount, total phenylephrine amount Arterial gas analysis 4 times after induction, at the start of manipulation of mandible, at the start of manipulation of maxilla, at the end of surgery.\nPr-operative and post-operative lab (Hb, Bun, Cr, OT, PT, Na, K) Intraoperative total fluid, total urine amount, total blood loss, transfusion amount.", 
            "measure": "the influence of antihypertensive agents on hemodynamic stability", 
            "safety_issue": "No", 
            "time_frame": "From the beginning until the end of hypoetensive anesthesiaan expected average of 65 mins.(From manipulration of Mandible to maxilla)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01839253"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Total minutes when the MAP is lower than 55mmHg and higher than 65mmHg (min) , The time below 55 mmHg(min) , The total time above 65 mmHg (min) Total remifentanil amount, total NTG amount, total phenylephrine amount Arterial gas analysis 4 times after induction, at the start of manipulation of mandible, at the start of manipulation of maxilla, at the end of surgery.\nPr-operative and post-operative lab (Hb, Bun, Cr, OT, PT, Na, K) Intraoperative total fluid, total urine amount, total blood loss, transfusion amount.", 
            "measure": "reduction of anaesthetics with control", 
            "safety_issue": "No", 
            "time_frame": "From the beginning until the end of hypoetensive anesthesia an expected average of 65 mins.(From manipulration of Mandible to maxilla)"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}